PMID- 31800041 OWN - NLM STAT- MEDLINE DCOM- 20201005 LR - 20201005 IS - 1569-9285 (Electronic) IS - 1569-9285 (Linking) VI - 30 IP - 3 DP - 2020 Mar 1 TI - Outcome of video-assisted thoracoscopic implantation of epicardial left ventricular leads with visual targeting for cardiac resynchronization therapy. PG - 373-379 LID - 10.1093/icvts/ivz276 [doi] AB - OBJECTIVES: Our goal was to analyse the implantation and outcome of thoracoscopic epicardial leads after a failed endovascular approach or follow-up (FU) complications after endovascular implantation. METHODS: We reviewed the records of patients with failed endovascular left ventricular (LV) lead placement or complications during FU, who were subsequently referred to cardiac surgeons for treatment with thoracoscopic LV lead implantation. We analysed the reasons for endovascular failure; the indications for the surgical procedures; and the clinical, echocardiographic and device FU results. RESULTS: Between 2010 and 2013, a total of 23 patients were included. Among them, 17 of the patients had no previous cardiothoracic surgery, 13 (76%) had successful video-assisted thoracoscopy (VAT) LV lead implantation, 3 (18%) had a conversion to thoracotomy and 1 (6%) failed. Of the 6 patients with prior cardiothoracic surgery, 2 (33%) had VAT only, 3 (50%) had primary thoracotomies and 1 (17%) had a conversion. Two major complications occurred. The reasons for LV endovascular lead failure were subclavian vein occlusion (n = 2), implant failure (n = 13) and complications during the FU period (n = 8). FU information was available for 20 patients: 17 (85%) had improved symptoms. The median FU period was 33 months. A total of 78% of patients were in New York Heart Association (NYHA) functional class III-IV before the operation; 30% were in NYHA functional class III-IV at the last FU examination. The left ventricular ejection fraction increased from 25% before surgery to 31% at the last FU examination. Overall, sensing and pacing threshold values remained stable over time. In 1 patient, lead revision was necessary due to an increase in the pacing threshold. CONCLUSIONS: VAT implantation of LV leads had an excellent response rate with an improvement in NYHA functional class and left ventricular ejection fraction. The lead measurements were mainly stable over time. CI - (c) The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. FAU - Stauber, Annina AU - Stauber A AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Tanner, Hildegard AU - Tanner H AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Noti, Fabian AU - Noti F AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Roten, Laurent AU - Roten L AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Seiler, Jens AU - Seiler J AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Lam, Anna AU - Lam A AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Medeiros-Domingo, Argelia AU - Medeiros-Domingo A AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Servatius, Helge AU - Servatius H AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Tran, Van Nam AU - Tran VN AD - Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Carrel, Thierry AU - Carrel T AD - Department of Cardiovascular Surgery, Bern University Hospital, University of Bern, Bern, Switzerland. FAU - Weber, Alberto AU - Weber A AD - Department of Cardiovascular Surgery, Bern University Hospital, University of Bern, Bern, Switzerland. LA - eng PT - Journal Article PL - England TA - Interact Cardiovasc Thorac Surg JT - Interactive cardiovascular and thoracic surgery JID - 101158399 SB - IM MH - Cardiac Resynchronization Therapy/*methods MH - Echocardiography MH - *Electrodes, Implanted MH - Female MH - Heart Failure/diagnosis/physiopathology/*therapy MH - Humans MH - Male MH - Middle Aged MH - Pericardium/*surgery MH - Stroke Volume/*physiology MH - Thoracic Surgery, Video-Assisted/*methods MH - Treatment Outcome MH - Ventricular Function, Left OTO - NOTNLM OT - Cardiac resynchronization therapy OT - Epicardial lead OT - Heart failure OT - Left ventricular lead OT - Thoracoscopic OT - Video-assisted thoracoscopic EDAT- 2019/12/05 06:00 MHDA- 2020/10/06 06:00 CRDT- 2019/12/05 06:00 PHST- 2019/07/12 00:00 [received] PHST- 2019/10/05 00:00 [revised] PHST- 2019/10/23 00:00 [accepted] PHST- 2019/12/05 06:00 [pubmed] PHST- 2020/10/06 06:00 [medline] PHST- 2019/12/05 06:00 [entrez] AID - 5652056 [pii] AID - 10.1093/icvts/ivz276 [doi] PST - ppublish SO - Interact Cardiovasc Thorac Surg. 2020 Mar 1;30(3):373-379. doi: 10.1093/icvts/ivz276.